Modulation of nitric oxide (NO) may offer novel approaches in the treatment of a variety of diseases, such as Alzheimer's, cardiovascular disease, and diabetes. A strategy in the modulation of NO expression may be through the use of herbal medicines. We surveyed medicinal plant research that utilized multicomponent extracts similar to what is used in clinical phytotherapy or in commerce, for demonstrated effects on NO activity. SciFinder Scholar, Pubmed, Web of Science, and BIOSIS were searched to identify human, animal, in vivo, ex vivo or in vitro research on botanical medicines, in whole or standardized form, that act on nitric oxide activity. iNOS was the most frequently investigated enzyme system and this system was up-regulated by many plant extracts,
Introduction
Well before Furchgott and Zawadzki 1 proved the existence of a labile endothelium-derived relaxing factor (EDRF), nitric oxide (NO) had been found to be a potent vasodilator and to play a role in platelet aggregation. The eventual identification of NO as endothelial-derived relaxation factor led to the Nobel Prize for Ignarro, Furchgott and Murad. This was also the beginning of the recognition of NO as a key to not only vascular dynamics, but as a messenger molecule in a variety of tissues and organs. 2 NO is a crucial intra-and extra-cellular communicator, modulating ion channels and messaging dynamics. 3 NO plays a pivotal role in physiological adaptation through its effects on vascular tone, proper neurotransmission, and proper immunological defense. 4 Currently, NO is reported to act as a central modulator of functions ranging from neurotransmission, gene response and second-signal messaging. 5 As a neurotransmitter, NO plays a role in a number of processes including memory formation, sleep, neuropathologies and aging. 6, 7 With regard to sleep, NO in the pontine tegmuntum enables the rapid eye movement stage. 6 NO also demonstrates a neuroprotective role for both glial and neuronal cells. 8 In the periphery, the network of non-adrenergic and non-cholinergic nerves operates through a nitric oxide-dependent mechanism regulating gastrointestinal, respiratory, and genitourinary tract functions. Additionally, erectile drugs act through neuronal generated NO. 9 As an immunogenic messenger, substantial quantities of NO produced for host defense significantly influence the processes of immune system coordination, response, and inflammation. 10 NO is generated by activated macrophages aiding in the response to infections, directly exerting antimicrobial activity, and affecting both innate and acquired immune function through the modulation of cytokine expression and leukocyte apoptosis. 10 The substrate for the production of NO is Larginine, a nitrogen rich amino acid shuttled through the L-arginine-nitric oxide pathway to meet the tissue specific enzyme, nitric oxide synthase (NOS). NOS releases picomoles of nitric oxide in response to receptor stimulation. 11 NOS is unique, it is both a hemeprotein and flavoprotein. NOS includes three isoforms: neuronal NOS, named NOS1 or nNOS, inducible NOS, known as NOS2 or iNOS, and an endothelial NOS, known as NOS3 or eNOS. 12 Two of the three identified isoforms of NOS (eNOS and iNOS) are found in endothelial cells. 13 iNOS, which is integral to the inflammatory process and capable of high output of NO during inflammation, is inducible while nNOS and eNOS are constitutive. 14 The three isoforms all require cofactors and prosthetic groups for activity, including FAD, FMN, heme, calmodulin, tetrahydrobiopterin and possibly thiols. 12, [15] [16] [17] Evidence suggests that a variety of diseases are related to defects in the action and regulation of NO and NOS. 7 In pathological conditions, the isoforms of NOS are observed to be regulated differently. 18 High output of NO is injurious to a variety of tissues. 14 For example, a possible mode of action for Alzheimer's disease may involve the inappropriate expression of NO by the apoE4 genotype. 19, 20 In addition, the inflammatory processes so commonly associated with obesity are associated with higher levels of NO. 21, 22 In diabetes, eNOS and nNOS are down-regulated, while iNOS is up-regulated. 18 In aging, neuropathologies, and parasitemia, induction of iNOS, are observed. 6 Deficiencies in the production of NO inhibit adhesion molecules and cytokine expression and diminish leukocyte transmigration. 23 Insufficient NO release in the gastric associated lymphoid tissue, a key immunological site accounting for over 60% of all lymphoid tissue in the body, has been shown to be problematic for mucosal blood flow, gastrointestinal motility, mucus formation and bacteriostasis. 24 Thus, the NO pathways are involved in many pathological processes. Even though they are structurally similar, NOS isoforms differ in their dependence on Ca ++ . 25 The constitutive isoforms in the brain and vasculature are regulated by calcium and calmodulin while the inducible iNOS, found in macrophages, is calcium independent. 7 Thus, transcriptional and post-transcriptional regulation of these various isoforms is distinct rendering therapeutic intervention specific to iNOS, eNOS or nNOS. 18, 26, 27 This heterogeneity provides the potential for specific therapeutic targets in the modulation of NO expression; a goal of pharmaceutical research due to the panoply of diseases with which NO is associated. For example, corticoids inhibit the induction of iNOS while proinflammatory cytokines may induce iNOS. 7 Previous studies have shown dietary variables to have an impact on NO expression. [28] [29] [30] [31] [32] [33] [34] It is sensible, therefore, to consider the effect of plants in both a dietary and a medicinal scenario. Medicinal plants have been shown to influence a number of fundamental cellular processes and more research is being carried out into the effects of medicinal plants on NO. For example, Wang and Mazza 35 demonstrated that the anti-inflammatory effects of specific anthocyanin and proanthocyanin rich plants may be due in part to the inhibition of NO production. A review of the primary literature suggests that many of the effects of herbal remedies involve up-or down-regulation of such messengers as NO, cytokines and adhesion molecules. [36] [37] [38] [39] This review of the primary literature demonstrates the effects of plant-based medicines on the expression of NO. Historically, the therapeutic use of medicinal plants included an array of diverse constituents or groups of constituents due to the phytochemical matrix of plant-based medicines. 40 As Islam and Carter suggest, 41 research into isolated constituents to reveal the modes of activity of herbal medicines loses sight of the principles of phytotherapy. Moreover, clinicians using medicinal plants in their practice generally use phytotherapeutic remedies that contain multiple constituents. Therefore, in order to maintain relevance to modern phytotherapy, this review was limited to herbal medicines that are available in the market place or preparations that represent multi-component phytochemical mixtures representative of a plant-based medicine approach.
Materials and Methods

Search strategy
The primary literature was searched in Pubmed, Web of Science, BIOSIS, and SciFinder Scholar. Titles were screened for all hits to the terms herbs and nitric oxide, medicinal plants and nitric oxide, Chinese medicine and nitric oxide, and Ayurveda and nitric oxide. The search only included English language papers.
Criteria for inclusion
The following inclusion criteria were adopted: i) Investigations on whole herbs or plant parts (e.g. seed, leaf, root, stem, flower or entire plant) or standardized extracts. Research on isolated constituents or herbal formulations were rejected. Fungi, although technically not plants, were included as they are commonly used in phytotherapy. ii) Model types were considered. In vitro, ex vivo, in vivo, animal and human models were accepted. iii) Two out of three of the following criteria were required to be transparent in the investigation: method of preparation of the botanical medicine, concentration of the plant preparation, or dose/exposure time. iv) Only studies demonstrating activity with regard to nitric oxide that showed a statistically significant result (P<0.05) were included.
Results
Out of 451 papers reviewed, only 44 papers met the established selection criteria. Data collected as a result of searches are shown in Tables 1-6. The majority of the research used in vitro models, but in vivo animal models were also utilized. Data in Tables 1-6 list the Genus species of the plants researched, followed by the plant parts used, methods of preparation, concentration/dose, duration of exposure, model utilized, nitric oxide pathway affected and references. Tables 1 and 2 show ex vivo results. Tables 3-6 list the in vitro results utilizing cell culture categorized by solvents used for the medicinal plant extractions (aqueous, ethanolic, and other extractions). The tables are divided into columns denoting the medicinal plant species, type of preparation/extraction (aqueous, ethanolic, powder etc.), concentration/dosage used, duration of exposure, the cell type, inducing agent and model (in vivo, ex vivo or in vitro). If one or more of these variables differed in an investigator's series of experiments (e.g. plant part, cell model or dose) a separate listing for each experimental condition is listed. The most common model employed for assaying NO activity was based on the Greiss assay that uses sulfanilamide and N-1napthylethylenediamine to monitor the output of nitrite, a stable by product of NO production. The terms increase or decrease were used for these models. Investigations measuring enzyme concentration of NOS isoforms utilized Western blots (showing direct upregulation of NOS protein) or PCR was utilized to show the direct upregulation of NOS genes. The terms induction or inhibition were used for these models. The term stimulation was used to denote measures of increased NOS activity.
A large volume of research did not meet the inclusion criteria. Much of the rejected research was based on isolated constituents and offered little relevance for clinical phytotherapy. [85] [86] [87] Research of semi-purified compounds like curcumin (a mixture of curcuminoids) or bromelain (a mixture of proteolytic enzymes) or isolates such as indole-3-carbinol were included only if they were readily available in commerce and/or frequently used by phytotherapists. One particular paper reporting a series of investigations that screened 83 plant extracts was included in this review. 75 However, due to the high dosage utilized in the screening process (80 μg/mL), only the six plant extracts that demonstrated dose dependent responses at the lowest dose that achieved over 40% inhibition of NO expression were included from this series of investigations. 75 The majority of the available studies located on NO and medicinal plants generated data based on in vitro work. Of these, only 15 studies had concentrations of extracts that were at or below 10 μg/mL. These included Crataegus pinnatifida, Ixeris dentate, Chasalia chartacea, Hedyotis verticillata, Lasianthus oblongus, Leea indica, Litsea cubeba, Spermacoce articularis, Thymus pulegioides, Brassica spp. (as the isolate indole-3-carbinol), Cocos nucifera, Echinacea angustifolia (combined with E. purpurea), Echinacea purpurea, Kalopanax pictus and Phellinus linteus. With rare exceptions, most in vitro models utilized macrophages and thus studied iNOS activity.
The significant findings of this literature review are that there are a multitude of medicinal plants that modulate the NO/NOS system. These effects are highlighted in Tables 1-6 . Some of the most frequently used medicinal plants appear to interface with the NOS system. For example, Centella asiatica and Echinacea purpurea, both common medicinal plants, show activity on immune related NO release. However, C. asiatica was found to be an inhibitor of iNOS, while E. purpurea demonstrated increases in NO release in ex vivo models. In an in vitro murine macrophage model E. purpurea was found to both increase and decrease iNOS activity as assessed by NO concentrations. Ginkgo biloba has also demonstrated decreases in iNOS activity and, as a result, in NO release in human macrophages. Two plants from the Ayurvedic system, Rubia cordifolia and Tinospora cordifolia, have both been found to inhibit iNOS activity and NO release in ex vivo models. Multiple other plants have also been found to be active in the reviewed studies as shown in Tables 1-6.
Discussion
The due to the use of in vitro and animal models in the bulk of the reviewed investigations. Replicating physiologically relevant models of human physiology are difficult with in vitro methods. Cells that survive, divide and then are utilized by in vitro experimental models are often poorly representative of cellular conditions in vivo, especially with regard to gene expression and enzyme levels. 88 In addition, in vitro models fail to account for the digestive and metabolic processing of the multiple compounds present within a plant extract. In vitro models are also often poor representations of physiologically relevant serum concentrations. Moreover, the increased oxygen exposure in cell-culture conditions leads to more reactive oxygen species (ROS) generation and may impair cellular antioxidant defences. 41 In considering in vitro research involving NOS and NO that are dependent on redox reactions, increased ROS generation due to cell culture conditions may have a dramatic impact on the results of these assays.
Animal models also may misrepresent human physiology. Artificially generated pathology, confounding variables, differences in anatomy and biochemical pathways all call into question the validity of data gathered from animal models. Accordingly, caution must be used when extrapolating data from in vitro and in vivo animal models. While in vitro and animal research models provide less than strong evidence, traditional use of medicinal plants has been shown to offer leads to biochemical and physiological effects of traditional remedies. For example, of 6,350 proven antimicrobial plant species, around 63% have ethnomedical documentation as antimicrobials. 89 Additionally, 75% of new drugs made from nat- Decrease/Increase, levels; Induction/Inhibition, enzyme models (NOS); Stimulation, increased enzyme activity; TG, thioglycolate; L-NAME, L-N(G)-nitroarginine methyl ester hydrochloride; LPS, lipopolysaccharide. ural products were discovered by following leads from traditional use of medicinal plants. 90 Thus, the reviewed data, which demonstrates the effects of herbal extracts on NO activity and NOS expression, may offer meaningful insight into the physiological activity and potential therapeutic indications when put into the context of traditional use. Furthermore, given the broad spectrum activity via stimulation of cell-to-cell communication by NO and, in turn, the broad spectrum activity of phytomedicines which can be viewed as complex chemical remedies, it is likely that some of the organ and tissue effects of these remedies are due, at least in part, to modulation of NO expression.
Review
In the past decade, NO has been recognized as a primary messenger molecule of paramount functional significance with broad spectrum activity. The activity of NO is not dependent primarily on NOS isoforms but rather on NO concentrations, leukocyte priming, and cellular context. 23 NO has been found to be a pleiotropic mediator of inflammation. 91 In addition, dependent on concentration, NO is involved in protection against or induction of oxidative stress in many tissues. With this dual role in mind, Cooke 92 suggests a yin/yang effect of NO in physiological function. Overproduction of NO is of primary importance and is proinflammatory, inducing cellular damage via oxidative stress, characterizing atherosclerosis, as well as insulin resistance. Conversely, a reduction in production of NO may be involved in initiation and progression of atherosclerosis. 23, [92] [93] [94] The endothelial isoform of NOS, eNOS, is believed to play a role in limiting the acute phase of inflammation by inhibiting leukocyte activation and platelet aggregation, and by inducing vasodilatation. 95 Achike and Kwan 95 also recognize pleiotropic activity of NO as yin/yang suggesting that an imbalance in vascular function relates to the yin (vascular relaxation) and yang (vascular contraction) balance of the system. They suggest that hypertension is due to an excessive yang nature, while hypotension is considered excessive yin nature. Ou et al. 96 suggest that herbs that show strong antioxidant activity were yin in nature after comparing the results of herbs known in traditional Chinese medicine as yin or yang that were evaluated by the oxygen radical absorbance capacity (ORAC) assay. Intriguingly, of the herbs suggested to be yin in nature, many are, in the proper clinical context, used to treat cardiac conditions, including hypertension which is commonly considered a yang condition. These include Astragalus membranaceous, Crataegus pinnatifida, Emblica officinalis, Eucommia ulmoides, Evolvulus alsinoides, Nigella sativa and Oldenlandia diffusa.
Cooke's 92 suggestion of NO having an amphoteric effect relates to the activity of some of the reviewed medicinal plants that are believed to amphoterically regulate physiology. For example, extracts from Echinacea spp., once thought to be simple immune stimulants, have shown both immune enhancing and immune dampening effects. Echinacea extracts have demonstrated immune stimulatory activity in mice, 97 cattle, 98 and humans. 99 The alkylamides of Echinacea spp. have also shown increases in the proinflammatory tumor necrosis factor alpha in macrophages (TNF-α). 100 Conversely, recent studies demonstrate downregulation of the inflammatory cytokines by the alkylamides, including IL-1, 101 IL-2, 102 IL-12, 101 TNF-α, 101, 103 as well as by an Echinacea extract (IL-1β, IL-8, TNF-α) consumed by adult humans. 104 With regard to the effect of Echinacea extracts on NO, Goel et al. 44 and Rininger et al. 81 report an increase in the production of NO from macrophages. In contrast, Stevenson et al. revealed an inhibitory effect on NO production from macrophages. Both Rininger and Stevenson's in vitro models were in the range of physiologically relevant serum concentrations and used lipopolysaccharide as a macrophage primer. Nonetheless, they show opposing activity. This may be due to one extract undergoing simulated digestion while the other represented only the lipophilic fraction of E. purpurea radix. These studies demonstrate the folly of relying only on in vitro results for understanding pharmacology where the context of pathophysiological condition is difficult to replicate. This may also be an example of various constituents having opposing activities in medicinal plant extracts. Another example of a medicinal plant that influences the NO pathways is turmeric (Curcuma longa) which has been used historically as both a food spice and medicine throughout India and southeast Asia. Traditional applications of the plant include treatment of inflammation, skin wounds and tumors. 105 Clinical trials have investigated the efficacy of both turmeric extract and curcumin, an isolated mixture of the yellow/orange pigments known as curcuminoids that give turmeric its characteristic color. Curcumin is widely available on the market and used in irritable bowel syndrome, colorectal cancer, pancreatitis, osteoarthritis and peptic and gastric ulcers. 106 Research has demonstrated the antiinflammatory, 107 antioxidant, 108 and anticarcinogenic 109 activity of curcumin. These effects are suggested to involve multiple pathways and modes of activity, such as inhibition of IL-8 production and signal transmission, 109 inhibition of TNF-α, 107 inhibition of the transcription factor NFκB, 110 and the scavenging effects and induction of antioxidant enzymes. 111 Of interest, the NO pathways link turmeric to all three activities: anti-inflammatory, antioxidant and anticarcinogenic activity. Since nitric oxide is found to be elevated when inflammation is present, the ability of turmeric to inhibit nitric oxide is a possible partial explanation for its anti-inflammatory properties. In the course of screening Asian anti-inflammatory herbs for inhibitory activity of nitric oxide synthesis, a crude extract of Curcuma zedoaria showed significant inhibitory activity as compared to other herbs. The crude methanolic extract of Curcuma zedoaria was found to inhibit the synthesis of nitric oxide by 78% in vitro. 80 Nitric oxide inhibition may also be a causative factor in the anticarcinogenic activity of turmeric and curcumin. iNOS is overexpressed in colonic tumors of humans and also in murine models. In an animal study on colon tumor development, curcumin was found to inhibit colonic aberrant crypt foci formation by 45% (P<0.001), an indicator of its anticarcinogenic and iNOS inhibitory activity. 112 There is evidence to suggest that the antioxidant activity of turmeric and curcumin are also linked to nitric oxide modulation. The effects of curcumin on the nitric oxide pathway in cardiac tissue and cultured cells were studied on rats with induced diabetes. One month of induced diabetes caused an upregulation of both eNOS and iNOS mRNA levels in the heart. Treatment of the diabetic rats with curcumin reduced eNOS and iNOS levels in association with reduced oxidative DNA and protein damage. 113 Many medicinal plants, which influence the NOS system also contain reasonable concentrations of folate. 114 Serum homocysteine concentrations, which are reduced by folate, are suspected to cause the accumulation of asymmetrical dimethylarginine (ADMA). ADMA impairs NO synthesis and therefore accelerates atherosclerosis. 115 Hence the combination of NOS modulating constituents in the reviewed plants and the nutrient folate may additively or synergically act against atherosclerosis.
Besides secondary metabolites, primary metabolites of plants have also shown an effect on NO. For example, α-linolenic acid has been shown to lower the release of eicosanoids and NO from human aortic endothelial cells. 116 Arginine, another primary metabolite of plants and the substrate of NOS, yields NO as a product. Clinical trials on patients with coronary or peripheral arterial disease have demonstrated increases in walking distance, exercise capacity, and quality of life, with a decrease in symptoms when supplemented with arginine. 31, 32, 34 This suggests that arginine rich foods, which generally come from plant-based proteins, may have positive NO activity resulting in beneficial cardiovascular effects. 117, 118 This provides yet another pathway, in addition to folate and secondary metabolites, by which medicinal plants may have an influence on vascular dynamics. NO signaling represents a fundamental process in the body that appears to be modulated by a large number of plants. While this is pharmacologically intriguing, it frames a larger question about the role of phytochemistry in mammalian physiology. Considered from an evolutionary time scale, NO activity appears to have been modulated by plant compounds for millions of years. While the study of NO modulation by phytochemicals is enticing and deserves further investigation, future research should also consider the effects on physiological processes when NO signaling is not routinely modulated due to decreased phytochemical intake. 119 This may offer further insights into chronic disease processes.
Conclusions
The reviewed data demonstrate that many medicinal plants have effects on the nitric oxide pathways. Considering the observations made by traditional healers, modern phytotherapists, and laboratory researchers regarding the reviewed plants, the beneficial activity of these medicinal plants may be partially due to effects on the nitric oxide pathways. Many of these reviewed medicinal plant species may be appropriate in nitric oxide based conditions. Further studies are needed to clarify the clinical therapeutics of these chemically complex remedies. 
